Yamashita, Shizuya
Masuda, Daisaku
Matsuzawa, Yuji
Article History
First Online: 23 January 2020
Compliance with Ethical Standards
:
: SY received honoraria from Kowa Company Ltd., Kowa Pharmaceutical Co. Ltd., MSD K.K., Bayer Yakuhin, Ltd., Amgen-Astellas BioPharma K.K., Sonofi K.K., Skylight Biotech Inc., East Japan Institute of Technology Co., Ltd.; clinical research funding from MSD K.K., Bayer Yakuhin, Ltd., Boehringer Ingelheim Japan, Inc., AstraZeneca Co., Takeda Pharmaceutical Co., Ltd., Astellas Pharma Inc., Mitsubishi Tanabe Pharma Co., Kyowa Medex Co., Ltd., ROHTO Pharmaceutical Co., Ltd., Fujirebio Inc.; scholarship grants from Astellas Pharma Inc., Boehringer Ingelheim Japan, Inc., MSD K.K., Bayer Yakuhin, Ltd., Takeda Pharmaceutical Co., Ltd.; and courses endowed by companies from Izumisano City and Kaizuka City. DM received a grant for joint research from Kowa Pharmaceutical Co. Ltd., Boehringer Ingelheim Japan, Inc., MSD K.K., Astra Zeneca K.K., Kyowa Medex Co., Ltd., Fujirebio Company and clinical research funding from Takeda Pharmaceutical Company Limited, Ono Pharmaceutical Co., Ltd. YM has no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.